Lemtrada 58468-0200-01
Generic: Alemtuzumab
- Manufacturer
- Genzyme Corporation
- Dosage Form
- Injection, Solution, Concentrate
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- November 18, 2014
- Listing Expires
- December 31, 2026
- Application
- BLA103948
Need to source Lemtrada? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Alemtuzumab | 12 mg/1.2mL |
Drug Class
CD52-directed Cytolytic Antibody [EPC]CD52-directed Antibody Interactions [MoA]CD52-directed Cytolytic Antibody [EPC]
Selected Package
58468-0200-01Selected1 VIAL, SINGLE-USE in 1 CARTON (58468-0200-1) / 1.2 mL in 1 VIAL, SINGLE-USE